NASDAQ: KLRAKailera Therapeutics Inc Stock Ownership - Who owns Kailera Therapeutics?
Insider buying vs selling
Have Kailera Therapeutics Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Ronald C. Renaud Jr. | CEO President | 2026-06-09 | 38,094 | $5.25 | $199.99kBuy |
| Bain Capital Investors LLC | 10% Owner | 2026-04-20 | 8,398,438 | $16.00 | $134.38MBuy |
| Bain Capital Life Sciences Investors LLC | 10% Owner | 2026-04-20 | 1,562,500 | $16.00 | $25.00MBuy |
| Andrew T. Kaplan | Director | 2026-04-20 | 8,398,438 | $16.00 | $134.38MBuy |
| Adam Koppel | Director | 2026-04-20 | 1,562,500 | $16.00 | $25.00MBuy |
| Rtw Investments LP | 10% Owner | 2026-04-20 | 500,000 | $16.00 | $8.00MBuy |
KLRA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when KLRA insiders and whales buy or sell their stock.
KLRA Shareholders
What type of owners hold Kailera Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Andrew T. Kaplan | 20.25% | 26,255,581 | $337.38M | Insider |
| Bain Capital Investors LLC | 20.25% | 26,255,581 | $337.38M | Insider |
| Bain Capital Life Sciences Investors LLC | 17.42% | 22,583,268 | $290.19M | Insider |
| Adam Koppel | 17.42% | 22,583,268 | $290.19M | Insider |
| Rtw Investments LP | 8.31% | 10,776,820 | $138.48M | Insider |
| Jiangsu Hengrui Pharmaceuticals Co Ltd | 1.57% | 2,034,134 | $26.14M | Insider |
| Ronald C. Renaud Jr. | 0.03% | 38,094 | $489.51k | Insider |
| Bainca | 0.02% | 26,256 | $337.39k | Institution |
| Bain Capital Investors LLC | 0.02% | 26,255 | $337.38k | Institution |
| Bain Capital Life Sciences Investors LLC | 0.02% | 22,583 | $290.19k | Institution |
KLRA vs Biotech Stocks
Kailera Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.